image: Overcoming immune resistance to attack tumor cells via inhibition of β-cat-BCL9. This material relates to a paper that appeared in the May 8th, 2019, issue of Science Advances, published by AAAS. The paper, by M. Feng at Fudan University in Shanghai, China, and colleagues was titled, "Pharmacological inhibition of β-catenin/BCL9 interaction overcomes resistance to immune checkpoint blockades by modulating Treg cells." view more
Credit: S. Kaulitzki